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Human Immunodeficiency Virus (HIV) andMycobacterium tuberculosis (M.tb) are among
the most lethal human pathogens worldwide, each being responsible for around
1.5 million deaths annually. Moreover, synergy between acquired immune deficiency
syndrome (AIDS) and tuberculosis (TB) has turned HIV/M.tb co-infection into a major
public health threat in developing countries. In the past decade, autophagy, a lysosomal
catabolic process, has emerged as a major host immune defense mechanism against
infectious agents like M.tb and HIV. Nevertheless, in some instances, autophagy
machinery appears to be instrumental for HIV infection. Finally, there is mounting
evidence that both pathogens deploy various countermeasures to thwart autophagy.
This mini-review proposes an overview of the roles and regulations of autophagy in
HIV and M.tb infections with an emphasis on microbial factors. We also discuss the
role of autophagy manipulation in the context of HIV/M.tb co-infection. In future, a
comprehensive understanding of autophagy interaction with these pathogens will be
critical for development of autophagy-based prophylactic and therapeutic interventions
for AIDS and TB.
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Introduction
Autophagy is an intracellular self-digestion process whereby cytoplasmic constituents are delivered
to and degraded by lysosomes (Lamb et al., 2013). Besides being crucial for quality control and
energy supply, autophagy plays key roles in immune defenses against invading bacterial and
viral pathogens, such as regulation of inflammation, antigen presentation and microorganism
capture and degradation (Deretic et al., 2013; Richetta and Faure, 2013; Huang and Brumell,
2014). Autophagy is a tightly regulated process that involves more than 30 dedicated autophagy-
related proteins (Atgs) (Lamb et al., 2013). The process is initiated by two complexes, Ulk1
and Beclin-1, leading to the formation of cup-shaped isolation membrane (Figure 1A). This
membrane expands to sequester cytoplasmic target and then closes to form a double-membrane
bound organelle termed the autophagosome. Autophagosome biogenesis requires two ubiquitin-
like conjugates: Atg12-Atg5 and LC3-phosphatidylethanolamine. Ultimately, autophagosome
undergoes fusion with lysosomes leading to the degradation of engulfed material. Cytoplasmic
cargo is recognized and then captured by the autophagy machinery via specific LIR domain-
containing autophagic adaptors/receptors that binds directly to LC3 (Deretic et al., 2013).
Globally, Ser/Thr kinase mammalian target of rapamycin (mTOR) represses autophagy, but
many mTOR-independent pathways can also participate in its regulation (Ravikumar et al.,
2010).
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FIGURE 1 | Schematic representation of autophagic pathways and
modulators involved in M. tuberculosis infection. (A) Principal steps in
autophagosome biogenesis and maturation (i.e., lysosomal delivery).
Autophagy begins with the formation of an isolation membrane that grows to
enclose cytoplasmic cargo marked with autophagic adaptors. Once sealed,
the autophagosome fuses with lysosomes to allow degradation of
sequestered cargo. Numerous signaling pathways regulate autophagy
including master repressor Ser/Thr kinase mTOR. (B) M.tb-autophagy
interaction in macrophage. Following phagocytosis, M.tb resides in a vacuole
called phagosome and blocks phagosome maturation. Several
immunological and pharmaceutical autophagy inducers can restore delivery
of M.tb to lysosomes. Esx-1-secreting M.tb promotes phagosome damages
which trigger ubiquitination, recruitment of autophagic adaptors and
mycobacterial capture via STING, Parkin and DRAM1. M.tb extracellular
DNA (eDNA) and cyclic-di-adenosine monophosphate (c-di-AMP) activate
autophagy whereas Eis and ManLAM inhibit this process. Note that ManLAM
was not studied in the context of infection. *Esx-1 blocks autophagosome
maturation in human dendritic cells. Vit D3, vitamin D3; TLR, toll-like receptor.
Green box, M.tb factors activators of autophagy. Red box, M.tb factors
inhibitors of autophagy.
Autophagy in M. tuberculosis Infection and
Countermeasures
The capacity ofM.tb to survive and replicate in host macrophages
is central to M.tb pathogenesis, with intracellular growth being
often associated with virulence (Hmama et al., 2015; Weiss
and Schaible, 2015). M.tb has developed several schemes to
avoid antimicrobial mechanisms of macrophages and thus
survive intracellularly. One of significance is its ability to block
phagosome maturation right after phagocytosis thereby avoiding
the hostile environment of phagolysosomes and consequently
killing (Vergne et al., 2004; Russell, 2011). Importantly, Deretic
and collaborators have shown that phagosome maturation
and mycobacterial killing can be restored through exogenous
induction of autophagy in infected macrophages (Gutierrez et al.,
2004).
Since then, several laboratories confirmed this seminal
discovery with functionally diverse immunological and
pharmacological autophagy inducers, such as IFNγ, Vitamin
D3, ATP, toll-like receptor (TLR) ligands, M.tb-specific T-cells
and FDA-approved drugs (Bradfute et al., 2013; Parihar et al.,
2014; Schiebler et al., 2014; Stanley et al., 2014) (Figure 1B).
Autophagy induction not only results in fusion of lysosomal
compartments with mycobacterial phagosome but also triggers
the generation of neo-antimicrobial peptides, essential for
mycobacterial killing (Alonso et al., 2007; Ponpuak et al.,
2010). Moreover, autophagy may play an indirect role in
M.tb phagocytosis through regulation of scavenger receptors
expression (Bonilla et al., 2013). In addition to these in vitro
studies, in vivo experiments have demonstrated that autophagy
protein Atg5 in macrophages is required to curtailM.tb infection
in mice (Castillo et al., 2012; Watson et al., 2012) and that
autophagy inhibitors enhances mycobacterial load in zebrafish
embryo model (Van Der Vaart et al., 2014). Notably, several
reports revealed that some populations of TB patients display
polymorphisms in genes linked to the autophagy pathway,
namely, IRGM, IFNγ, IFNγ receptor, TLR8, Vitamin D3 (VDR),
and ATP receptor (P2X7R), suggesting that some individuals
might be more prone to develop TB due to a defective autophagic
response (Songane et al., 2012). Current TB treatment involves
a cocktail of antimicrobial drugs, among them isoniazid and
pyrazinamide. Interestingly, a recent study suggests that these
drugs, in addition to their direct bactericidal activity, may also
act by promoting autophagy (Kim et al., 2012a). Lastly, in mouse
model, increase of autophagy activity during BCG vaccination
appears to improve antigen presentation and vaccine efficiency
(Jagannath et al., 2009).
Although limited and/or incomplete, autophagy is induced
in macrophages as a result of M.tb infection. The molecular
mechanisms involved in this activation are just starting to be
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unraveled with two converging signaling pathways described
so far (Figure 1B). The first one is a stimulation of interferon
genes (STING)-dependent cytosolic DNA sensing pathway that
triggers ubiquitination of damaged M.tb-containing phagosome
(Watson et al., 2012). Mycobacterial type VII secretion system
Esx-1 damages phagosomal membrane and is thus essential
to induce this pathway. Both M.tb extracellular DNA (eDNA)
and cyclic-di-adenosine monophosphate (c-di-AMP) participate
in STING signaling (Watson et al., 2012; Dey et al., 2015).
The ensued ubiquitination, mediated in part by ubiquitin
ligase Parkin, promotes the recruitment of autophagic adaptors,
p62 and NDP52, then LC3 binding and autophagic capture
(Watson et al., 2012; Manzanillo et al., 2013). The second
is a TLR/MyD88/NF-kB pathway that induces expression of
the DNA damage-regulated autophagy modulator DRAM1.
DRAM1-induced autophagy requires STING and p62 expression
(Van Der Vaart et al., 2014). However, the role of NF-kB in
M.tb-induced autophagy is probably complex, since its inhibition
was also shown to promote autophagy in infected THP-1
macrophages (Bai et al., 2013). Finally, another layer of regulation
may be achieved through expression of microRNA-155 that
targets GTPase Rheb, an activator of mTOR (Wang et al., 2013).
However, this view has been challenged by another group who
showed that M.tb infection enhances mTOR activity (Zullo and
Lee, 2012).
In the past 5 years, several reports have revealed that M.tb
inhibits autophagy during infection, and that this inhibition
could be important for mycobacterial pathogenicity and/or
virulence. In contrast to avirulent strain M.tb H37Ra, virulent
strain M.tb H37Rv limits autophagy by upregulating the
expression of host anti-autophagic factor Bfl-1/A1 (Kathania
et al., 2011). A genome-wide analysis identified additional
host genes involved in autophagy inhibition during M.tb
H37Rv infection (Kumar et al., 2010). Knockdown of these
genes resulted in autophagy-mediated killing of mycobacteria
in THP-1 macrophages. Although, some of them have their
expression increased during infection, their role in autophagy
regulation remains ill-defined. Another host protein important
for hampering ubiquitin-dependent autophagic capture of M.tb
is Coronin-1a (Seto et al., 2012). To this point, three M.tb
products have been shown to suppress autophagy in phagocytes
(Figure 1B). A M.tb glycoconjugate, lipoarabinomannan
(ManLAM), inhibits autophagy in macrophages by an unknown
mechanism (Shui et al., 2011; Vergne et al., 2014). The study
was performed using purified molecules and it is thus unclear
whether ManLAM is essential for autophagy regulation during
infection and if other mycobacterial factors are involved in
that process. More recently, the Esx-1secretion system, a M.tb
virulence factor, has been implicated in inhibition of autophagic
flux in human dendritic cells (Romagnoli et al., 2012). Finally,
M.tb-secreted Eis is an N-acetyltransferase that blocks autophagy
by targeting JNK signaling pathway in murine macrophages
(Shin et al., 2010; Kim et al., 2012b).
Overall, these literature data underscore autophagy
functionality as a major determinant of M.tb control.
Nevertheless, numerous questions remain to be addressed
such as the role of autophagy-related proteins and the regulation
of autophagy in variousM.tb infected-immune and non-immune
cells. The molecular mechanisms involved inM.tb manipulation
of autophagy needs to be fully characterized as well as the link
withM.tb virulence.
Autophagy in HIV Infection and
Countermeasures
HIV-1 infects mainly CD4 T lymphocytes, macrophages and
Dendritic Cells (DCs), but its cytopathic effects is mainly
characterized by a decline in the CD4 T-cell population (Ameisen
and Capron, 1991; Terai et al., 1991). HIV can also access the
brain, where it infects and replicates in macrophages, microglial
cells, astrocytes and neural precursors, leading to cognitive
deficits known as HIV-Associated Neurocognitive Disorders
(HAND) (Braathen, 1988; Cavrois et al., 2008; Letendre, 2011).
Several mechanisms are involved in the CD4 T cell demise
in HIV-infected patients but, it seems that, although concurrent
mechanisms such as pyroptosis have been proposed (Doitsh
et al., 2014), most of them die by apoptosis, and that the
majority of apoptotic cells are uninfected bystander cells
(Ameisen and Capron, 1991; Terai et al., 1991). HIV-1 proteins
such as the envelope glycoproteins (Env), the transactivator
Tat and the accessory proteins Vpr and Nef, have been
involved in modulating the uninfected CD4 T cell death, but
accumulating evidences suggest that Env plays a major role in
this process (Varbanov et al., 2006). In this context, infected cells
expressing Env at their surface are able to activate autophagy
in uninfected CD4 T cells, leading to apoptosis (Espert et al.,
2006; Denizot et al., 2008) (Figure 2). While autophagy is
induced in uninfected CD4 T cells, it is downregulated in these
productively infected cells, suggesting that the virus has evolved
strategies to circumvent autophagy antiviral effect (Zhou and
Spector, 2008; Espert et al., 2009). Accordingly, a significant
increase in autophagy has been detected in the Peripheral Blood
Mononuclear Cells of patients that are HIV controllers, i.e.,
patients that remain asymptomatic for more than 10 years or
because they are able to control viremia below the detection limit
(Nardacci et al., 2014). At the molecular level, autophagy restricts
HIV-1 infection by selectively degrading the viral transactivator
Tat but the viral protein Vif is able to inhibit the early steps
autophagy allowing the productive infection of CD4 T cells
(Borel et al., 2014; Sagnier et al., 2015) (Figure 2). Moreover,
rhesus TRIM5 α protein can act as an autophagy receptor since
it interacts with the HIV-1 capsid protein and leads to its
degradation (Mandell et al., 2014).
Autophagy is not induced in uninfected cells from the
monocyte/macrophage lineage after contact with Env-expressing
cells (Espert et al., 2009). The secreted form of the HIV-Tat
protein could be responsible for the absence of autophagy
induction by activating Src-Akt and STAT3 signaling pathways,
previously known to inhibit autophagy (Van Grol et al.,
2010) (Figure 2). Moreover, the release of Tat by infected
cells upregulates IL-10 (Badou et al., 2000) and these two
factors can lead to an autophagy blockade in neighboring,
uninfected macrophages, independently of the presence of Env
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FIGURE 2 | Schematic representation of interactions between HIV
and the autophagy pathway. A complex relationship exists between
HIV and the autophagy process in the different targeted cell types.
Functional autophagy is an anti-HIV process as it promotes
degradation of the viral protein Tat, limits virion production and HIV
antigen presentation. However, HIV can block the autophagy pathway
at the initiation step (Env in dendritic cells; Tat in uninfected
macrophages; Vif in infected CD4 T cells) or at the maturation step
(Nef in infected macrophages). Notably, the blockade of autophagy
maturation by Nef, in infected macrophages, can be beneficial for HIV.
In uninfected CD4 T cells, Env-induced autophagy is a prerequisite for
the induction of apoptosis. Viral determinants that are inducers of
autophagy are indicated in green, and viral determinants that inhibit
this process are indicated in red.
(Van Grol et al., 2010). Tat also suppresses IFN-γ-induced
autophagy in macrophages by suppressing Stat1 phosphorylation
(Li et al., 2011). Conversely, autophagosomes are accumulated
in infected macrophages where Nef, by interaction with Beclin
1, blocks autophagy before its degradative step (Espert et al.,
2009; Kyei et al., 2009). The HIV-1 precursor Gag was found
in complexes with LC3 and was also present in LC3-II-
enriched membranes, suggesting that autophagy could favor
Gag processing and viral particles production in these cells
(Kyei et al., 2009). Notably, the degradative step of autophagy
has an anti-HIV-1 activity that must be controlled by the
virus to prevent its degradation (Figure 2). Nef also interacts
with the cellular immunity-associated GTPase familyM (IRGM)
promoting autophagosomes accumulation and improving HIV
replication. The anti-HIV activity of autophagy is also evidenced
by reports showing that TLR8 ligands activate a vitamin D3-
mediated autophagic response that inhibits HIV-1 multiplication
in macrophages (Campbell and Spector, 2011, 2012b).
The viral protein ASP (AntiSens Protein), which is produced
from a transcript initiating from the promoter-harboring 3’-
long terminal repeat region of the viral genome, has been
shown to partially co-localize with LC3 (Clerc et al., 2011;
Torresilla et al., 2013). ASP expression could induce autophagy
in the promonocytic U937 cells and, consequently, increase
viral replication. ASP could also be a target for autophagic
degradation, allowing the regulation of its expression as it
was already demonstrated for the Human T-Lymphtropic Virus
(HTLV) protein Tax (Tang et al., 2013; Torresilla et al., 2013).
In DCs, the viral replication intermediates could be
transported into the lysosome in an autophagy-dependent
manner and regulate IFN-α secretion upon TLR7-mediated
ssRNA recognition (Lee et al., 2007; Zhou et al., 2012). Moreover,
autophagy inhibition has been shown to impair TLR-mediated
innate immune response while also strongly affecting antigen
processing and MHC-II-mediated antigen presentation to CD4
T cells (Blanchet et al., 2010) (Figure 2).
HIV can invade the central nervous system and autophagy has
been proposed to participate in HAND but the exact mechanisms
of the HIV-mediated alteration of the autophagic pathway
is poorly understood. Autophagic vacuoles accumulation has
been observed in post-mortem brain from patients with HIV-
associated encephalitis (Zhou et al., 2011). Notably, autophagy
is a key pathway regulating aging and HIV patients developing
HAND have symptoms usually associated with an aged brain
and increased susceptibility to neuropathologies (Fields et al.,
2013).
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Importantly, several studies demonstrated that the ATGs
can exert some effects independently of the autophagic process
(Bestebroer et al., 2013). Indeed, while it becomes obvious that
autophagy has an anti-HIV effect, a genome-wide RNAi screen
has demonstrated that some ATG proteins are required for HIV-
1 replication (Brass et al., 2008). Accordingly, it has been shown
that HIV-1 replication can be delayed in stable ATG knockdown
cell lines (Eekels et al., 2012). These studies highlighted a role
of autophagy separated from the effect of ATG proteins alone
during HIV infection.
In conclusion, the autophagy/HIV relationship is complex and
depends mainly on the targeted cell types and their infectious
status (Figure 2). In the future, it would be interesting to decipher
the Env-induced signaling pathways leading to autophagy-
dependent apoptosis and to study autophagy regulation in
different cohort of patients in parallel to in vitro experiments.
This is of particular importance considering that bystander CD4
T lymphocytes constitute the majority of dying cells during HIV
infection, leading to AIDS. Because autophagy is an anti-HIV
process blocked by the virus for its replication, the development
of drugs inducing this process could be beneficial for the patients.
Autophagy in TB/HIV Co-infections
Synergy between HIV-1 and M.tb is a very severe problem.
Each pathogen favors infection by the other. Indeed, M.tb is
responsible for 26% of deaths in HIV-infected patients, and 39%
of new M.tb cases concern HIV-1 positive patients (Harrington,
2010; Chang et al., 2013). This deadly association is especially
critical in sub-saharan Africa and a warning has been launched
“When will we act” (Harries et al., 2010).
It is largely unknown how infection by HIV-1 facilitates
infection by M.tb (Anandaiah et al., 2011; Diedrich and
Flynn, 2011). Nevertheless, the development of HIV-1 infection
strongly affects the immune system and thus prevents the
development of an efficient cellular response against M.tb
(Chang et al., 2013). The main target of HIV-1 is the
CD4+ T-cell (Perelson et al., 1996) and only < 10% of
macrophages are infected in patients (Kedzierska et al., 2003;
Sandler and Douek, 2012). This is due to a combination
of several factors such as low expression of HIV-1 receptor
(CD4) and coreceptor (CXCR5) on macrophages (Alexaki
et al., 2008) and the expression in this cell type of SAMHD1
that is able to inhibit HIV-1 multiplication (Hrecka et al.,
2011). Nevertheless, the macrophage infection rate by HIV-
1 is substantially increased upon opportunistic infection and
doubly infected macrophages have been observed within the
lymph nodes of a patient co-infected with HIV-1 and M.avium
(Orenstein et al., 1997) and in alveolar macrophages from a
patient co-infected with HIV-1 and M.tb (Mwandumba et al.,
2004). Upon coinfection of the same macrophage, inhibition of
the autophagy pathway by the first invader will likely benefit the
second.
More generally, it seems clear that manipulation of the
immune response by HIV-1 and M.tb favors the multiplication
of the other pathogen. For instance, the induction of IL-10
secretion by HIV-1 (Badou et al., 2000; Rayne et al., 2004) was
found to inhibit apoptosis of macrophages upon M.tb infection
(Patel et al., 2009). More globally, this immunosuppressive
Th2 cytokine will hamper the cellular immune response to
M.tb (Jasenosky et al., 2015). In the other direction, M.tb
infection was found to increase IL-8 levels (Friedland et al.,
1992) and this cytokine, by inducing the homing of T-cells
to lymph nodes, will favor HIV-1 multiplication (Ott et al.,
1998).
A key effector allowing the immune system to fight both
HIV-1 and M.tb is vitamin D. It is produced in the skin
through exposure to ultraviolet B. It is considered that half of
the human population have vitamin D insufficiency and this
deficiency is much more widespread and pronounced in HIV-
1 infected patients (Borella et al., 2014). The active metabolite
of vitamin D is 1α,25-dihydroxy-cholecalciferol (1,25D3) which
is produced by the kidney and proinflammatory cells, in
particular during infection. Upon binding to its receptor,
1,25D3 will enhance the expression of β-defensin 2/4 and
4A genes as well as cathelicidin (Liu et al., 2006; Borella
et al., 2014). These peptides are mediators of antibacterial and
antiviral responses, and cathelicidin induces the transcription
of ATG5, Beclin1 and NOD2 that are key components of
the autophagy pathway (Yuk et al., 2009; Borella et al.,
2014).
1,25D3 is thus an important physiological inducer of
autophagy, a process that is involved in cell defense against
both HIV-1 and M.tb. (Deretic, 2012). Indeed 1,25D3 was
found to inhibit both HIV-1 and M.tb multiplication in
an autophagy-dependent manner (Campbell and Spector,
2012c; Anandaiah et al., 2013). Inhibition of HIV-1 or
M.tb growth by physiological levels of 1,25D3 is dependent
on Beclin-1 and ATG5, and this is also the case when
macrophages are infected with both pathogens (Campbell
and Spector, 2012c). Vitamin D-induced autophagy was
also found to rely on cathelicidin to eliminate HIV-1 and
M.tb either alone or in coinfection (Campbell and Spector,
2012c).
The capacity of vitamin D to induce autophagy and inhibit
the growth of HIV-1 and M.tb has been reviewed in detail
elsewhere (Jo, 2010; Campbell and Spector, 2012a). Although
supplementation of vitamin D led to contrasting results it seems
clear that a normal level of this vitamin helps the immune system
to fight several type of bacterial and viral infections (Borella et al.,
2014).
Conclusions and Perspectives
Here, we have gathered compelling published data that reveal the
major functions and regulationmechanisms of autophagy in HIV
and M.tb infections. However, despite considerable progress,
our understanding of autophagy in these deadly infections
remains largely incomplete. An in-depth comprehension of the
intricate interplay between HIV, M.tb and autophagy, both
in vitro and in vivo, will undoubtedly unveil novel strategies
employed by pathogens to subvert this pathway. Furthermore,
this research avenue could also lead to improved knowledge
of the autophagy pathway itself and to innovative tools for
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 June 2015 | Volume 5 | Article 49
Espert et al. Autophagy in TB and HIV infections
autophagy manipulation, as it was recently achieved with Nef-
Beclin-1 interaction (Kyei et al., 2009; Shoji-Kawata et al., 2013).
Although several challenges have to be overcome, in particular
the multiple and complexes roles of autophagy in infection
and cellular homeostasis, autophagy manipulation holds great
potentials for future development of new or improved vaccines
and therapies for infectious diseases (Espert et al., 2006; Kyei
et al., 2009; Rubinsztein et al., 2012; Mostowy, 2013; Levine et al.,
2015; Wallis and Hafner, 2015).
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